HFS
VKTX icon

Hughes Financial Services’s Viking Therapeutics VKTX Stock Holding History

Hughes Financial Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78 Sell
2
-3
-60% -$97 ﹤0.01% 1501
2026
Q1 		$163 Buy
5
+3
+150% +$96 ﹤0.01% 1153
2025
Q4 		$70 Buy
+2
New +$71 ﹤0.01% 1111
2025
Q2 		– Sell
-36
Closed -$861 – 1242
2025
Q1 		$861 Buy
+36
New +$1.14K ﹤0.01% 739

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Hughes Financial Services's VKTX Position: Q2 2026 in Review

Hughes Financial Services reduced its Viking Therapeutics (VKTX) stake by 60% in Q2 2026, selling an estimated $97 and leaving 2 shares worth $78. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Hughes Financial Services first reported a position in VKTX in Q1 2025 and has held it in 4 quarters since. The position peaked at $861 in Q1 2025. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • Hughes Financial Services held 2 shares of Viking Therapeutics worth $78 as of Q2 2026.
  • Hughes Financial Services sold 3 Viking Therapeutics shares in Q2 2026, an estimated $97.
  • Viking Therapeutics made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1501 holding.
  • Hughes Financial Services first reported a position in Viking Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Hughes Financial Services's Viking Therapeutics position peaked at $861 in Q1 2025.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.